NATIONAL VISION HOLDINGS INC (EYE) Fundamental Analysis & Valuation

NASDAQ:EYE • US63845R1077

Current stock price

27.43 USD
-0.63 (-2.25%)
At close:
27.43 USD
0 (0%)
After Hours:

This EYE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EYE Profitability Analysis

1.1 Basic Checks

  • In the past year EYE was profitable.
  • In the past year EYE had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: EYE reported negative net income in multiple years.
  • EYE had a positive operating cash flow in each of the past 5 years.
EYE Yearly Net Income VS EBIT VS OCF VS FCFEYE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • With a Return On Assets value of 1.49%, EYE perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
  • EYE has a Return On Equity of 3.40%. This is comparable to the rest of the industry: EYE outperforms 57.72% of its industry peers.
  • With a Return On Invested Capital value of 3.13%, EYE perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
  • EYE had an Average Return On Invested Capital over the past 3 years of 2.03%. This is significantly below the industry average of 13.16%.
  • The 3 year average ROIC (2.03%) for EYE is below the current ROIC(3.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.49%
ROE 3.4%
ROIC 3.13%
ROA(3y)-0.99%
ROA(5y)0.89%
ROE(3y)-2.68%
ROE(5y)2.1%
ROIC(3y)2.03%
ROIC(5y)2.99%
EYE Yearly ROA, ROE, ROICEYE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • EYE has a Profit Margin (1.49%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of EYE has declined.
  • Looking at the Operating Margin, with a value of 3.48%, EYE is in the better half of the industry, outperforming 60.16% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EYE has declined.
  • EYE's Gross Margin of 58.77% is amongst the best of the industry. EYE outperforms 86.99% of its industry peers.
  • EYE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.48%
PM (TTM) 1.49%
GM 58.77%
OM growth 3Y2.39%
OM growth 5Y-13.36%
PM growth 3Y-10.81%
PM growth 5Y-6.82%
GM growth 3Y2.96%
GM growth 5Y1.69%
EYE Yearly Profit, Operating, Gross MarginsEYE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. EYE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EYE is destroying value.
  • Compared to 1 year ago, EYE has more shares outstanding
  • The number of shares outstanding for EYE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, EYE has an improved debt to assets ratio.
EYE Yearly Shares OutstandingEYE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
EYE Yearly Total Debt VS Total AssetsEYE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.38 indicates that EYE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EYE has a Altman-Z score (2.38) which is comparable to the rest of the industry.
  • EYE has a debt to FCF ratio of 3.35. This is a good value and a sign of high solvency as EYE would need 3.35 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.35, EYE is in the better half of the industry, outperforming 72.36% of the companies in the same industry.
  • A Debt/Equity ratio of 0.26 indicates that EYE is not too dependend on debt financing.
  • EYE has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: EYE outperforms 59.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.35
Altman-Z 2.38
ROIC/WACC0.37
WACC8.44%
EYE Yearly LT Debt VS Equity VS FCFEYE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • EYE has a Current Ratio of 0.55. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EYE has a Current ratio of 0.55. This is amonst the worse of the industry: EYE underperforms 89.43% of its industry peers.
  • EYE has a Quick Ratio of 0.55. This is a bad value and indicates that EYE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EYE has a Quick ratio of 0.33. This is in the lower half of the industry: EYE underperforms 69.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.33
EYE Yearly Current Assets VS Current LiabilitesEYE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EYE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.45% over the past year.
  • Measured over the past years, EYE shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.44% on average per year.
  • Looking at the last year, EYE shows a quite strong growth in Revenue. The Revenue has grown by 9.00% in the last year.
  • EYE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.03% yearly.
EPS 1Y (TTM)45.45%
EPS 3Y9.46%
EPS 5Y-1.44%
EPS Q2Q%475%
Revenue 1Y (TTM)9%
Revenue growth 3Y-0.3%
Revenue growth 5Y3.03%
Sales Q2Q%15.12%

3.2 Future

  • Based on estimates for the next years, EYE will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.12% on average per year.
  • Based on estimates for the next years, EYE will show a small growth in Revenue. The Revenue will grow by 5.81% on average per year.
EPS Next Y16.61%
EPS Next 2Y19.69%
EPS Next 3Y20.04%
EPS Next 5Y19.12%
Revenue Next Year5.01%
Revenue Next 2Y5.79%
Revenue Next 3Y6.23%
Revenue Next 5Y5.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EYE Yearly Revenue VS EstimatesEYE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
EYE Yearly EPS VS EstimatesEYE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. EYE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 34.29, the valuation of EYE can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of EYE is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of EYE to the average of the S&P500 Index (25.23), we can say EYE is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 29.40 indicates a quite expensive valuation of EYE.
  • EYE's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.51. EYE is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 34.29
Fwd PE 29.4
EYE Price Earnings VS Forward Price EarningsEYE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as EYE.
  • EYE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 29.67
EV/EBITDA 15.2
EYE Per share dataEYE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as EYE's earnings are expected to grow with 20.04% in the coming years.
PEG (NY)2.06
PEG (5Y)N/A
EPS Next 2Y19.69%
EPS Next 3Y20.04%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EYE Dividend Analysis

5.1 Amount

  • EYE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EYE Fundamentals: All Metrics, Ratios and Statistics

NATIONAL VISION HOLDINGS INC

NASDAQ:EYE (3/26/2026, 8:18:09 PM)

After market: 27.43 0 (0%)

27.43

-0.63 (-2.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners119.33%
Inst Owner Change3.52%
Ins Owners1.94%
Ins Owner Change15.38%
Market Cap2.18B
Revenue(TTM)1.99B
Net Income(TTM)29.60M
Analysts81.33
Price Target33.97 (23.84%)
Short Float %12.23%
Short Ratio7.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)72.44%
Min EPS beat(2)-1.54%
Max EPS beat(2)146.42%
EPS beat(4)3
Avg EPS beat(4)46.16%
Min EPS beat(4)-1.54%
Max EPS beat(4)146.42%
EPS beat(8)7
Avg EPS beat(8)46.08%
EPS beat(12)11
Avg EPS beat(12)45.79%
EPS beat(16)14
Avg EPS beat(16)36.31%
Revenue beat(2)2
Avg Revenue beat(2)1.24%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.85%
Revenue beat(4)4
Avg Revenue beat(4)1.34%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)0.01%
Revenue beat(12)7
Avg Revenue beat(12)0.02%
Revenue beat(16)8
Avg Revenue beat(16)-0.29%
PT rev (1m)0%
PT rev (3m)1.22%
EPS NQ rev (1m)3.91%
EPS NQ rev (3m)5.05%
EPS NY rev (1m)0.27%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 34.29
Fwd PE 29.4
P/S 1.1
P/FCF 29.67
P/OCF 14.9
P/B 2.51
P/tB N/A
EV/EBITDA 15.2
EPS(TTM)0.8
EY2.92%
EPS(NY)0.93
Fwd EY3.4%
FCF(TTM)0.92
FCFY3.37%
OCF(TTM)1.84
OCFY6.71%
SpS25.02
BVpS10.95
TBVpS-1
PEG (NY)2.06
PEG (5Y)N/A
Graham Number14.04
Profitability
Industry RankSector Rank
ROA 1.49%
ROE 3.4%
ROCE 4.4%
ROIC 3.13%
ROICexc 3.2%
ROICexgc 8.41%
OM 3.48%
PM (TTM) 1.49%
GM 58.77%
FCFM 3.7%
ROA(3y)-0.99%
ROA(5y)0.89%
ROE(3y)-2.68%
ROE(5y)2.1%
ROIC(3y)2.03%
ROIC(5y)2.99%
ROICexc(3y)2.12%
ROICexc(5y)3.35%
ROICexgc(3y)5.64%
ROICexgc(5y)9.12%
ROCE(3y)2.85%
ROCE(5y)4.21%
ROICexgc growth 3Y6.59%
ROICexgc growth 5Y-11.38%
ROICexc growth 3Y6.03%
ROICexc growth 5Y-9.62%
OM growth 3Y2.39%
OM growth 5Y-13.36%
PM growth 3Y-10.81%
PM growth 5Y-6.82%
GM growth 3Y2.96%
GM growth 5Y1.69%
F-Score8
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 3.35
Debt/EBITDA 1.43
Cap/Depr 79.91%
Cap/Sales 3.66%
Interest Coverage 3.62
Cash Conversion 91.26%
Profit Quality 248.15%
Current Ratio 0.55
Quick Ratio 0.33
Altman-Z 2.38
F-Score8
WACC8.44%
ROIC/WACC0.37
Cap/Depr(3y)98.71%
Cap/Depr(5y)101.6%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.45%
EPS 3Y9.46%
EPS 5Y-1.44%
EPS Q2Q%475%
EPS Next Y16.61%
EPS Next 2Y19.69%
EPS Next 3Y20.04%
EPS Next 5Y19.12%
Revenue 1Y (TTM)9%
Revenue growth 3Y-0.3%
Revenue growth 5Y3.03%
Sales Q2Q%15.12%
Revenue Next Year5.01%
Revenue Next 2Y5.79%
Revenue Next 3Y6.23%
Revenue Next 5Y5.81%
EBIT growth 1Y72.85%
EBIT growth 3Y2.08%
EBIT growth 5Y-10.74%
EBIT Next Year134.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.57%
FCF growth 3Y134.45%
FCF growth 5Y-14.22%
OCF growth 1Y9.46%
OCF growth 3Y7.07%
OCF growth 5Y-9.04%

NATIONAL VISION HOLDINGS INC / EYE Fundamental Analysis FAQ

What is the fundamental rating for EYE stock?

ChartMill assigns a fundamental rating of 4 / 10 to EYE.


What is the valuation status for EYE stock?

ChartMill assigns a valuation rating of 2 / 10 to NATIONAL VISION HOLDINGS INC (EYE). This can be considered as Overvalued.


Can you provide the profitability details for NATIONAL VISION HOLDINGS INC?

NATIONAL VISION HOLDINGS INC (EYE) has a profitability rating of 5 / 10.


What is the valuation of NATIONAL VISION HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NATIONAL VISION HOLDINGS INC (EYE) is 34.29 and the Price/Book (PB) ratio is 2.51.


Can you provide the financial health for EYE stock?

The financial health rating of NATIONAL VISION HOLDINGS INC (EYE) is 4 / 10.